Clinical effectiveness of telepharmacy services in patients with non‐communicable diseases in ambulatory care settings
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Clinical Effectiveness of Telepharmacy Services in Patients With Non‐communicable Diseases in Ambulatory Care Settings." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440395/all/Tumour_necrosis_factor‐alpha_antagonists_for_treatment_of_paediatric_Crohn’s_disease_New. Accessed 23 April 2024.
Clinical effectiveness of telepharmacy services in patients with non‐communicable diseases in ambulatory care settings. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440395/all/Tumour_necrosis_factor‐alpha_antagonists_for_treatment_of_paediatric_Crohn’s_disease_New. Accessed April 23, 2024.
Clinical effectiveness of telepharmacy services in patients with non‐communicable diseases in ambulatory care settings. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/440395/all/Tumour_necrosis_factor‐alpha_antagonists_for_treatment_of_paediatric_Crohn’s_disease_New
Clinical Effectiveness of Telepharmacy Services in Patients With Non‐communicable Diseases in Ambulatory Care Settings [Internet]. In: Cochrane Abstracts. [cited 2024 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440395/all/Tumour_necrosis_factor‐alpha_antagonists_for_treatment_of_paediatric_Crohn’s_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Clinical effectiveness of telepharmacy services in patients with non‐communicable diseases in ambulatory care settings
ID - 440395
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440395/all/Tumour_necrosis_factor‐alpha_antagonists_for_treatment_of_paediatric_Crohn’s_disease_New
DB - Evidence Central
DP - Unbound Medicine
ER -